BackBactiQuant A/S Overview

BactiQuant A/S EBIT

Track BactiQuant A/S's EBIT ($-11M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$2.22M
↑ 30.68% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

-$10.56M
↑ 10.91% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

BactiQuant A/S (BACTIQ.CO) FAQ

As of the most recent data (June 2026), BACTIQ.CO shows a EBIT of $-11M. That compares with $-12M in the prior-year period — up 10.9% year over year. That is below the sector sector average of $2.6T. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BACTIQ.CO's EBIT is now $-11M (was $-12M) — a 10.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether BactiQuant A/S is outperforming or lagging.

The its sector sector average EBIT is about $2.6T. BactiQuant A/S is at $-11M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how BACTIQ.CO stacks up against individual peers as well.

Tracking BACTIQ.CO's ebit over time shows whether BactiQuant A/S is scaling, shrinking, or reshaping that part of the business. The current reading is $-11M That compares with $-12M in the prior-year period — up 10.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has BactiQuant A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-11M) with ownership activity and broader fundamentals.